Vera Therapeutics, Inc. Common Stock, Value, Issued
Vera Therapeutics, Inc. (VERA) had Common Stock, Value, Issued of $72.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:CommonStockValue · last filed 2026-08-10
- 2026-06-30: Common Stock, Value, Issued $72.00K.
- 2026-03-31: Common Stock, Value, Issued $72.00K.
- 2025-12-31: Common Stock, Value, Issued $71.00K.
- 2025-09-30: Common Stock, Value, Issued $64.00K.
| Period end | Common Stock, Value, Issued |
|---|---|
| 2026-06-30 | $72.00K 10-Q · filed 2026-08-10 |
| 2026-03-31 | $72.00K 10-Q · filed 2026-05-07 |
| 2025-12-31 | $71.00K 10-Q · filed 2026-08-10 |
| 2025-09-30 | $64.00K 10-Q · filed 2025-11-05 |
| 2025-06-30 | $64.00K 10-Q · filed 2025-08-05 |
| 2025-03-31 | $64.00K 10-Q · filed 2025-05-07 |
| 2024-12-31 | $64.00K 10-K · filed 2026-02-26 |
| 2024-09-30 | $55.00K 10-Q · filed 2024-11-07 |
| 2024-06-30 | $55.00K 10-Q · filed 2024-08-08 |
| 2024-03-31 | $54.00K 10-Q · filed 2024-05-10 |
| 2023-12-31 | $44.00K 10-K · filed 2025-02-28 |
| 2022-12-31 | $28.00K 10-K · filed 2024-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| Viridian Therapeutics, Inc.\DE (VRDN) | United States | $2.342B | -5.38 |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 |